ସ୍ତନ କ୍ୟାନ୍ସର

Postmastectomy radiotherapy (PMRT) is unequivocally beneficial in reducing the recurrences as well as improving survival in node positive breast cancer patients. PMRT for women with T1-T2 tumors and negative axillary nodes is not generally warranted because of the presumed low risk of recurrence in this population as a whole. However, in the setting of multiple adverse prognostic factors, the recurrence risk approaches and in some cases surpasses the risk of recurrence documented for patients with one to three positive lymph nodes. Numerous retrospective series have reported the outcome and pa…

ସ୍ପୋନ୍ସର: ଟାଟା ମେମୋରିଆଲ୍ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT02992574 · CTRI ନମ୍ବର CTRI/2016/12/007532
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 10 ଏପ୍ରିଲ 2025 · ଆମ ଦ୍ୱାରା ପଢ଼ାଯାଇଛି 20 ଅକ୍ଟୋବର 2026